(A) Summary of analysis pipeline and generated results. Details of data sources are available in Supplementary file 1. (B) Effect size (WHRadjBMI) and odds ratio (T2DadjBMI) of lead genetic variant …
Genetic, transcriptomic, and epigenomic data sources in Figure 1.
(A) Tissue-specific enrichment of chromatin states of variants in the 99% credible set of colocalized variants. (B) Tissue of action scores for association signals in the five discordant loci. …
Genetic, transcriptomic, and epigenomic data sources used in Figure 2.
(A) Biweight midcorrelation of adipose tissue eGenes expression with metabolic phenotypes (false discovery rate [FDR] <5%). From left to right: Homeostatic model assessment of insulin resistance …
Genetic, transcriptomic, and epigenomic data sources in Figure 3.
(A) β of the T allele of discordant variant rs6860588 with respect to waist-to-hip circumference adjusted for the body mass index (WHRadjBMI), T2DadjBMI, and colocalized effector genes (eGenes). (B) …
Genetic, transcriptomic, and epigenomic data sources in Figure 4 and Figure 4—figure supplements 1 and 2 .
Manhattan plot of associations at the 5q21.1 locus containing lead variant rs6860588 for (A) waist-to-hip circumference adjusted for the body mass index (WHRadjBMI) genome-wide association studies …
LocusCompare plot of associations with rs6752964 for (A) waist-to-hip circumference adjusted for the body mass index (WHRadjBMI) genome-wide association studies (GWAS) with T2DadjBMI GWAS, (B) …
Credible set of genetic variants in T2DadjBMI and WHRadjBMI colocalized loci.
Finemapping analysis of association signals in loci containing discordant association signals.
Multi-trait colocalization of body fat distribution component traits in discordant loci.
Variant effect predictions of discordant variants.
Tissue of action scores at colocalized loci.
Significant eQTL and sQTL colocalization results in coloc.
Significant eQTL and sQTL colocalization results in SMR.